Look Alike Sound Alike Drugs in Adults
Abstract
One of the main causes of patient injury worldwide is medication errors. Due to their orthographic (look-alike) and phonetic (sound-alike) characteristics, medications labeled as LASAs are a well-known source of drug errors that can be confused. When it comes to packaging, form, color, and/or size, look-alike and sound-alike medications are identical physically, but their names, dosages, and/or strengths sound similar. Brand-to-brand, brand-to-generic, and generic-to-generic name confusion can happen. prescribing, dispense, administer, monitor, transcribing or documenting. Errors in prescribing can be attributed to a variety of factors, including handwritten prescriptions that are difficult to read, verbal instructions, the use of dangerous acronyms, and choosing a LASA medication when using computerized prescriber order entry (CPOE). Over- or under-dose of intended or unexpected drugs, as well as incorrect dosing, are possible consequences of LASA mistakes. More data would enable evidence-based methods that could lower errors brought on by Lasa medications, particularly from real-world contexts.
Keywords:
Lasa errors, Medications, prescribing, Packaging
Downloads
Download data is not yet available.
References
1. Ciociano N, Grisi L, Bagnasco L, Elberti MG, Mazzarella M. Risk assessment of look‒alike, sound‒alike (LASA) medication errors in an Italian hospital pharmacy: A model based on the ‘Failure Mode and Effect Analysis’. J Health Soc Sci. 2017;2(1):47-64.
https://journalhss.com/wpcontent/uploads/JHHS21_47-64.pdf
2. Sattiraju V, Ligade VS, Muragundi P, Pandey R, Janodia MD. National and higher education institutions (HEIs) IP policies: comparison of Indian HEIs’ IP policies from a global perspective. Journal of the Knowledge Economy. 2023 Jun;14(2):1979-2006.
https://www.currentscience.ac.in/Volumes/109/07/1230.pdf
3. Arun K, Babu CJ, Laksmaiah P, Rao CB, Ravi B, Harshavardhan P. Techniques to improve the absorption of poorly soluble drugs. International journal of research in pharmacy and chemistry. 2012;2(2).
4. Shore DA, editor. Forces of change: New strategies for the evolving health care marketplace. John Wiley & Sons; 2012 Jun 20. https://www.google.com/search?q=north+shore-
5. Roussel P, Moll MC, Lassale B, Ragni J. Analyse d’un incident de la chaîne transfusionnelle et gestion du retour d’expérience. Transfusion clinique et biologique. 2009 Sep 1;16(4):407-22. https://cdn.who.int/media/docs/default-source/patient-safety/patient-safety-solutions/ps-solution1-look-alike-sound-alike-medication-names.pdf?sfvrsn=d4f b860b_8
6. Roberta AS, Monica C, Susanna C, Laura F, Andrea M, Paola M, Gaia M, Ettore N, Carlo P, Piera P, Felice R. Sicurezza dei pazienti e gestione del rischio clinico: la qualità dell'assistenza farmaceutica.
7. Rani TT, Brahmaiah B, Revathi B, Nama S, Baburao C. TARGETING OF ANTI CANCER DRUGS THROUGH NANOPARTICLES. https://www.academia.edu/75895370/Targeting_of_Anti_Cancer_Drugs_Through_Nanoparticles
8. Gomes AT, Salvador PT, Rodrigues CC, Silva MD, Ferreira LD, Santos VE. Patient safety in nursing paths in Brazil. Revista Brasileira de Enfermagem. 2017 Jan;70:146-54.
9. Berman A. Reducing medication errors through naming, labeling, and packaging. Journal of medical systems. 2004 Feb;28:9-29.
10. Agrawal A. Medication errors: prevention using information technology systems. British journal of clinical pharmacology. 2009 Jun;67(6):681. https://www.google.com/search?q=.+Agrawal+A.+Medication+errors%3A+prevention+using+in
11. Schulmeister L. Look-alike, sound-alike oncology medications. Clinical journal of oncology nursing. 2006 Feb 1;10(1):35. https://www.google.com/search?q=13.+Schulmeister+L.+Look-alike%2C+sound-alike+oncology+medications.2006%3B10(1)%3A35%E2%88%9241&rlz=1C1RXQR_enIN1076I
12. Ravilla S, Chandu BR, Nama S. Erythrocytes as carrier for drugs, enzymes and peptides. Journal of applied pharmaceutical science. 2012 Apr 30(Issue):166-76.
13. Poon EG, Cina JL, Churchill W, Patel N, Featherstone E, Rothschild JM, Keohane CA, Whittemore AD, Bates DW, Gandhi TK. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Annals of internal medicine. 2006 Sep 19;145(6):426-34.
14. Extemporaneous Formulation MO. Pharmaceutical Services Division, Ministry of Health Malaysia. http://www.pharmacy.gov.my/v2/sites/default/ files/document-upload/guide-handling-lasa.pdf
15. Morriss Jr FH, Abramowitz PW, Nelson SP, Milavetz G, Michael SL, Gordon SN, Pendergast JF, Cook EF. Effectiveness of a barcode medication administration system in reducing preventable adverse drug events in a neonatal intensive care unit: a prospective cohort study. The Journal of pediatrics. 2009 Mar 1;154(3):363-8.
16. Ravella S, Angel M, Subramanian H, Thangavel N, Namballa M, Lokesh D, Mishra AK, Nagaraju GV. Navigating the Future of Cancer Diagnosis: A Comprehensive Review of Novel Approaches for Community-Based Treatment. future.;1:6.
17. Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. Journal of the American Medical Informatics Association. 2004 Mar 1;11(2):104-12.
18. Askari R, Shafii M, Rafiei S, Abolhassani MS, Salarikhah E. Failure mode and effect analysis: improving intensive care unit risk management processes. International journal of health care quality assurance. 2017 Apr 18;30(3):208-15.
19. Roy R, Ma J. Impact of a policy change on pharmacists’ reporting of adverse drug reactions. The Canadian Journal of Hospital Pharmacy. 2018 Jul;71(4):227.
20. Al Tehewy M, El Hosseini M, Habil I, Abdel Maaboud M, Abdel Rahman S. A proactive risk management using failure mode and effects analysis for infusion therapy in a tertiary hospital intensive care unit in Egypt. Acta Medica Mediterranea. 2015 Jan 1;31:195-200.
21. Rodriguez‐Gonzalez CG, Martin‐Barbero ML, Herranz‐Alonso A, Durango‐Limarquez MI, Hernandez‐Sampelayo P, Sanjurjo‐Saez M, iPharma. Use of failure mode, effect and criticality analysis to improve safety in the medication administration process. Journal of Evaluation in Clinical Practice. 2015 Aug;21(4):549-59.
22. McNally KM, Page MA, Sunderland VB. Failure-mode and effects analysis in improving a drug distribution system. American Journal of Health-System Pharmacy. 1997 Jan 15;54(2):171-7
https://journalhss.com/wpcontent/uploads/JHHS21_47-64.pdf
2. Sattiraju V, Ligade VS, Muragundi P, Pandey R, Janodia MD. National and higher education institutions (HEIs) IP policies: comparison of Indian HEIs’ IP policies from a global perspective. Journal of the Knowledge Economy. 2023 Jun;14(2):1979-2006.
https://www.currentscience.ac.in/Volumes/109/07/1230.pdf
3. Arun K, Babu CJ, Laksmaiah P, Rao CB, Ravi B, Harshavardhan P. Techniques to improve the absorption of poorly soluble drugs. International journal of research in pharmacy and chemistry. 2012;2(2).
4. Shore DA, editor. Forces of change: New strategies for the evolving health care marketplace. John Wiley & Sons; 2012 Jun 20. https://www.google.com/search?q=north+shore-
5. Roussel P, Moll MC, Lassale B, Ragni J. Analyse d’un incident de la chaîne transfusionnelle et gestion du retour d’expérience. Transfusion clinique et biologique. 2009 Sep 1;16(4):407-22. https://cdn.who.int/media/docs/default-source/patient-safety/patient-safety-solutions/ps-solution1-look-alike-sound-alike-medication-names.pdf?sfvrsn=d4f b860b_8
6. Roberta AS, Monica C, Susanna C, Laura F, Andrea M, Paola M, Gaia M, Ettore N, Carlo P, Piera P, Felice R. Sicurezza dei pazienti e gestione del rischio clinico: la qualità dell'assistenza farmaceutica.
7. Rani TT, Brahmaiah B, Revathi B, Nama S, Baburao C. TARGETING OF ANTI CANCER DRUGS THROUGH NANOPARTICLES. https://www.academia.edu/75895370/Targeting_of_Anti_Cancer_Drugs_Through_Nanoparticles
8. Gomes AT, Salvador PT, Rodrigues CC, Silva MD, Ferreira LD, Santos VE. Patient safety in nursing paths in Brazil. Revista Brasileira de Enfermagem. 2017 Jan;70:146-54.
9. Berman A. Reducing medication errors through naming, labeling, and packaging. Journal of medical systems. 2004 Feb;28:9-29.
10. Agrawal A. Medication errors: prevention using information technology systems. British journal of clinical pharmacology. 2009 Jun;67(6):681. https://www.google.com/search?q=.+Agrawal+A.+Medication+errors%3A+prevention+using+in
11. Schulmeister L. Look-alike, sound-alike oncology medications. Clinical journal of oncology nursing. 2006 Feb 1;10(1):35. https://www.google.com/search?q=13.+Schulmeister+L.+Look-alike%2C+sound-alike+oncology+medications.2006%3B10(1)%3A35%E2%88%9241&rlz=1C1RXQR_enIN1076I
12. Ravilla S, Chandu BR, Nama S. Erythrocytes as carrier for drugs, enzymes and peptides. Journal of applied pharmaceutical science. 2012 Apr 30(Issue):166-76.
13. Poon EG, Cina JL, Churchill W, Patel N, Featherstone E, Rothschild JM, Keohane CA, Whittemore AD, Bates DW, Gandhi TK. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Annals of internal medicine. 2006 Sep 19;145(6):426-34.
14. Extemporaneous Formulation MO. Pharmaceutical Services Division, Ministry of Health Malaysia. http://www.pharmacy.gov.my/v2/sites/default/ files/document-upload/guide-handling-lasa.pdf
15. Morriss Jr FH, Abramowitz PW, Nelson SP, Milavetz G, Michael SL, Gordon SN, Pendergast JF, Cook EF. Effectiveness of a barcode medication administration system in reducing preventable adverse drug events in a neonatal intensive care unit: a prospective cohort study. The Journal of pediatrics. 2009 Mar 1;154(3):363-8.
16. Ravella S, Angel M, Subramanian H, Thangavel N, Namballa M, Lokesh D, Mishra AK, Nagaraju GV. Navigating the Future of Cancer Diagnosis: A Comprehensive Review of Novel Approaches for Community-Based Treatment. future.;1:6.
17. Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. Journal of the American Medical Informatics Association. 2004 Mar 1;11(2):104-12.
18. Askari R, Shafii M, Rafiei S, Abolhassani MS, Salarikhah E. Failure mode and effect analysis: improving intensive care unit risk management processes. International journal of health care quality assurance. 2017 Apr 18;30(3):208-15.
19. Roy R, Ma J. Impact of a policy change on pharmacists’ reporting of adverse drug reactions. The Canadian Journal of Hospital Pharmacy. 2018 Jul;71(4):227.
20. Al Tehewy M, El Hosseini M, Habil I, Abdel Maaboud M, Abdel Rahman S. A proactive risk management using failure mode and effects analysis for infusion therapy in a tertiary hospital intensive care unit in Egypt. Acta Medica Mediterranea. 2015 Jan 1;31:195-200.
21. Rodriguez‐Gonzalez CG, Martin‐Barbero ML, Herranz‐Alonso A, Durango‐Limarquez MI, Hernandez‐Sampelayo P, Sanjurjo‐Saez M, iPharma. Use of failure mode, effect and criticality analysis to improve safety in the medication administration process. Journal of Evaluation in Clinical Practice. 2015 Aug;21(4):549-59.
22. McNally KM, Page MA, Sunderland VB. Failure-mode and effects analysis in improving a drug distribution system. American Journal of Health-System Pharmacy. 1997 Jan 15;54(2):171-7
Published
31/03/2024
Statistics
138 Views | 84 Downloads
Citatons
How to Cite
Muchu , P. “Look Alike Sound Alike Drugs in Adults”. International Journal of Health Care and Biological Sciences, Vol. 5, no. 1, Mar. 2024, pp. 18-23, doi:10.46795/ijhcbs.v5i1.609.
Issue
Section
Review Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.